Literature DB >> 3741419

A human-mouse hybrid cell line that stably expresses chemotaxis to N-formylmethionyl-leucyl-phenylalanine.

R R Aksamit.   

Abstract

Human leukocytes, which contain monocytes and neutrophils that exhibit chemotaxis to fMet-Leu-Phe, were fused with the mouse macrophage RAW264-TG3 cell line, which exhibits chemotaxis to endotoxin-activated mouse serum but not to fMet-Leu-Phe. From such fusions twelve cell lines were isolated, all of which migrated to endotoxin-activated mouse serum. Four of the cell lines also exhibited chemotaxis to fMet-Leu-Phe, and of these cell lines, only one, WBC264-9, retained the capacity to migrate to fMet-Leu-Phe after culture for 20 or more passages. Determination of the number of chromosomes and analysis of the electrofocusing patterns of human and mouse hypoxanthine-guanine phosphoribosyltransferase activity showed that WBC264-9 was derived from a human-mouse cell fusion. WBC264-9, a stable macrophage cell line that exhibits chemotaxis to fMet-Leu-Phe, provides a model system to investigate attractant-specific biochemical reactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741419     DOI: 10.1016/s0006-291x(86)80595-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Automated real-time measurements of leukocyte chemotaxis.

Authors:  Nacima Hadjout; Xiuyun Yin; David A Knecht; Michael A Lynes
Journal:  J Immunol Methods       Date:  2007-01-12       Impact factor: 2.303

2.  Metallothionein mediates leukocyte chemotaxis.

Authors:  Xiuyun Yin; David A Knecht; Michael A Lynes
Journal:  BMC Immunol       Date:  2005-09-15       Impact factor: 3.615

3.  Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages.

Authors:  Christiane E Wobus; Stephanie M Karst; Larissa B Thackray; Kyeong-Ok Chang; Stanislav V Sosnovtsev; Gaël Belliot; Anne Krug; Jason M Mackenzie; Kim Y Green; Herbert W Virgin
Journal:  PLoS Biol       Date:  2004-11-30       Impact factor: 8.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.